UNITED THERAPEUTICS Corp (UTHR) reporting calendar
UNITED THERAPEUTICS Corp files periodic reports with the SEC as UTHR on Nasdaq. Atlas tracks 14 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 16 Jul 2026 – 13 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 6 May 2026
- Reports on record
- 14
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 30 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open UTHR market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 6 May 2026 | 36 days | 0001082554-26-000020 |
| 10-K | 31 Dec 2025 | 25 Feb 2026 | 56 days | 0001082554-26-000006 |
| 10-Q | 30 Sep 2025 | 29 Oct 2025 | 29 days | 0001082554-25-000034 |
| 10-Q | 30 Jun 2025 | 30 Jul 2025 | 30 days | 0001628280-25-036541 |
| 10-Q | 31 Mar 2025 | 30 Apr 2025 | 30 days | 0001082554-25-000023 |
| 10-K | 31 Dec 2024 | 26 Feb 2025 | 57 days | 0001082554-25-000005 |
| 10-Q | 30 Sep 2024 | 30 Oct 2024 | 30 days | 0001082554-24-000047 |
| 10-Q | 30 Jun 2024 | 31 Jul 2024 | 31 days | 0001082554-24-000035 |
| 10-Q | 31 Mar 2024 | 1 May 2024 | 31 days | 0001082554-24-000025 |
| 10-K | 31 Dec 2023 | 21 Feb 2024 | 52 days | 0001082554-24-000005 |
| 10-Q | 30 Sep 2023 | 1 Nov 2023 | 32 days | 0001082554-23-000031 |
| 10-Q | 30 Jun 2023 | 2 Aug 2023 | 33 days | 0001082554-23-000022 |
| 10-Q | 31 Mar 2023 | 3 May 2023 | 33 days | 0001082554-23-000012 |
| 10-K | 31 Dec 2022 | 22 Feb 2023 | 53 days | 0001082554-23-000005 |
Source: SEC EDGAR company submissions for CIK 0001082554. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.